PUBLICATIONS · 7884429
Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 1995 Mar
- First author
- Fyfe G
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Fyfe G
- type
- Author
- name
- Fisher RI
- type
- Author
- name
- Rosenberg SA
- type
- Author
- name
- Sznol M
- type
- Author
- name
- Parkinson DR
- type
- Author
- name
- Louie AC
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Fyfe G
- type
- Author
- name
- Fisher RI
- type
- Author
- name
- Rosenberg SA
- type
- Author
- name
- Sznol M
- type
- Author
- name
- Parkinson DR
- type
- Author
- name
- Louie AC
- type
- Author
- bibliography ids
- nci-bib-ba7386c2bd6c8c1642c7cdf0
- book metadata
- content sha256
- b66a1c061d9faa6ee2ae674c279aed7122446eeb81b44febf30cf3ced418985b
- document type
- citation
- dois
- 10.1200/JCO.1995.13.3.688
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:7884429
- immutable id
- pubmed:7884429@b66a1c061d9faa6ee2ae674c279aed7122446eeb81b44febf30cf3ced418985b
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 3
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 688-96
- volume
- 13
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 7884429
- provenance
- batch id
- 113cd9a3f1a8bf48d098
- provider
- NCBI PubMed ESummary
- record sha256
- b235a8f1006143ab0f0efd0bf5e7f528ce74ebb7358b932309530d18916de964
- response sha256
- 7ff1f3e7d59b211257eb2c865c0b20a1c75138ebda6e11a58279b514a06be809
- retrieved at
- 2026-09-09T23:45:18.960722+00:00
- publication date
- display
- 1995 Mar
- precision
- month
- year
- 1995
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/7884429/
- title
- Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.
Preserved source evidence · Not medical advice
Triangle